H-LGADMEDVCGR-OH

Ref. 3D-PP44413

Informations sur le produit

• Nom: H-LGADMEDVCGR-OH
• Synonymes: NH2-Leu-Gly-Ala-Asp-Met-Glu-Asp-Val-Cys-Gly-Arg-OH

Description

Peptide H-LGADMEDVCGR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LGADMEDVCGR-OH include the following: A high throughput, multiplexed and targeted proteomic CSF assay to quantify neurodegenerative biomarkers and apolipoprotein E isoforms status WE Heywood , A Baud, E Bliss, E Sirka - JoVE (Journal of , 2016 - jove.comhttps://www.jove.com/t/54541/a-high-throughput-multiplexed-targeted-proteomic-csf-assay-to Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot study V Blanchard , S Ramin-Mangata - Journal of Lipid , 2018 - ASBMBhttps://www.jlr.org/article/S0022-2275(20)33124-2/fulltext Predictors of Cognitive Decline in Healthy Middle-Aged Individuals with Asymptomatic Alzheimer's Disease R Tandon , L Zhao, CM Watson , M Elmor - Research , 2023 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002814/ isoform by targeted mass spectrometry across a clinical cohort (n= 800): a case study for SRM-based assay validation and methionine-containing proteotypic peptide R Simon, C Fonbonne, JC Lambert - Congracašs franacahttps://hal.science/hal-00960636/ Plasma proteome profiling to assess human health and disease PE Geyer , NA Kulak , G Pichler , LM Holdt, D Teupser - Cell systems, 2016 - cell.comhttps://www.cell.com/fulltext/S2405-4712(16)30072-2 Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer's disease and other neurodegenerative diseases M Rezeli , H Zetterberg , K Blennow, A Brinkmalm - EuPA Open , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2212968515300143 EuPA Open Proteomics M Rezeli , H Zetterberg , K Blennow, A Brinkmalm - cyberleninka.orghttps://cyberleninka.org/article/n/135520.pdf In vivo human apolipoprotein E isoform fractional turnover rates in the CNS KR Wildsmith, JM Basak , BW Patterson, Y Pyatkivskyy - PloS one, 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0038013 Relative quantification of sulfenic acids in plasma proteins using differential labelling and mass spectrometry coupled with 473 nm photo-dissociation analysis: A JV Guillaubez, D Pitrat, Y Bretonniacašre, J Lemoine - Talanta, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0039914022005410 Simultaneous mass spectrometry-based apolipoprotein profiling and apolipoprotein E phenotyping in patients with ASCVD and mild cognitive impairment I Begcevic Brkovic, B Zöhrer, M Scholz, M Reinicke - Nutrients, 2022 - mdpi.comhttps://www.mdpi.com/2072-6643/14/12/2474 Homocysteine, another risk factor for Alzheimer disease, impairs apolipoprotein E3 function H Minagawa, A Watanabe, H Akatsu , K Adachi - Journal of biological , 2010 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)60702-5/abstract Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls E Martaca­nez-Morillo , O Hansson , Y Atagi, G Bu - Acta , 2014 - Springerhttps://link.springer.com/article/10.1007/s00401-014-1266-2 Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e E Martaca­nez-Morillo , HM Nielsen, I Batruch - Journal of proteome , 2014 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr401060x New plasma LC-MS/MS assays for the quantitation of beta-amyloid peptides and identification of apolipoprotein E proteoforms for Alzheimer's disease risk DM Weber , JC Kim, SM Goldman - Journal of , 2023 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/10815589241246537 Erin E. Franklin2, 3, Fan Liao1, Hong Jiang1, David Holtzman1, 3, 4, Nigel J. Cairns1, 2, 3, 4, John C. Morris1, 3, 4, and Randall J. Bateman1, 3, 4 AT Baker-Nigh, KG Mawuenyega, JG Bollinger, V Ovod - 2016 - researchgate.nethttps://www.researchgate.net/profile/Vitaliy-Ovod/publication/309546365_Human_Central_Nervous_System_CNS_ApoE_Isoforms_Are_Increased_by_Age_Differentially_Altered_by_Amyloidosis_and_Relative_Amounts_Reversed_in_the_CNS_Compared_with_Plasma/links/5817b7e308aeffbed6c33e16/Human-Central-Nervous-System-CNS-ApoE-Isoforms-Are-Increased-by-Age-Differentially-Altered-by-Amyloidosis-and-Relative-Amounts-Reversed-in-the-CNS-Compared-with-Plasma.pdf Plasma apolipoprotein E3 and glucose levels are associated in APOE É›3/É›4 carriers AK Edlund, K Chen , W Lee, H Protas - Journal of , 2021 - content.iospress.comhttps://content.iospress.com/articles/journal-of-alzheimers-disease/jad210065 Identification of genetic variants influencing the human plasma proteome aca
 Johansson , S Enroth , M Palmblad - Proceedings of the , 2013 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1217238110 Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease A Giannisis, A Al-Grety, H Carlsson, K Patra - Alzheimer's research & , 2022 - Springerhttps://link.springer.com/article/10.1186/s13195-022-01058-9 Plasma apolipoprotein E levels, isoform composition, and dimer profile in relation to plasma lipids in racially diverse patients with Alzheimer's disease and mild A Giannisis, A Al-Grety, H Carlsson, JC Howell - Alzheimer's Research & , 2023 - Springerhttps://link.springer.com/article/10.1186/s13195-023-01262-1

• Marque: Biosynth